Surface Contamination Results Under USP <800>: Risk Approaches and Decision-Making

Tuesday, December 6, 2022

2:00 PM – 3:30 PM

Location: Mandalay Bay South Convention Center, Lagoon F, Level 2

CE Credits: 1.50 contact hours

Activity #: 0204-0000-22-284-L07-P
Activity #: 0204-0000-22-284-L07-T
Activity Type: Application-based
Target Audience: Pharmacist, Pharmacy Technician

Learning Objectives:

Summarize the USP recommendations regarding hazardous drug (HD) surface sampling.
Based on a review of recent literature and available resources, evaluate challenges to establishing HD surface sampling programs.
Apply concepts of drug hazard characteristics and exposure toxicity risk to HD surface sampling result evaluation.
Develop a strategy for HD surface sampling result analysis to reduce exposure risk.

Program Chair(s)

Elaine Strauss, PharmD, MS, BCSCP

Senior Consultant, Cleanrooms and Sterile Compounding
WorkingBuildings

Moderator(s)

Elaine Strauss, PharmD, MS, BCSCP

Senior Consultant, Cleanrooms and Sterile Compounding
WorkingBuildings

Faculty Member(s)

Janet Gould, PhD, CIH, DABT

Senior Principal Toxicologist
SafeBridge Lifesciences and Regulatory Group
J. Nicholas Rice, MS, CIH, CSP

Industrial Hygiene & Safety Manager
Intermountain Healthcare
Elaine Strauss, PharmD, MS, BCSCP

Senior Consultant, Cleanrooms and Sterile Compounding
WorkingBuildings